Precision Mental Health, Global Healing

 

Spectruth DAO is pioneering a new era in mental health and longevity care—where advanced science, compassionate therapy, and decentralized innovation converge. We’re building a global network of clinics and research centers, starting with breakthrough ibogaine therapy for PTSD and addiction in Ukraine and Poland, and expanding to holistic longevity and detox retreats in Patagonia and Scotland. Our mission: to predict, prevent, and personalize healing for those who need it most.

About Us

Our Mission & Vision

Spectruth envisions a world where PTSD, addiction, and chronic stress are no longer life sentences. By harnessing cutting-edge epigenetic biomarkers, AI-powered diagnostics, and decentralized science, we enable early detection and tailored interventions for mental health and wellness.

Our Global Roadmap: Four Phases of Impact

  • Phase 1: Ukraine Ibogaine Clinic (2025) 
    Launching our first clinic to deliver legal, medically supervised ibogaine therapy for PTSD and addiction, while synthesizing pharmaceutical-grade ibogaine and developing proprietary intellectual property (IP-NFTs).
  • Phase 2: Poland Ibogaine Research Center (2026)  
    Expanding our clinical and research footprint, we’ll open a dedicated center in Poland to refine personalized protocols and scale access to ibogaine therapy across Central Europe.
  • Phase 3: Patagonia Longevity & Detox Clinic (2027)  
    Establishing a destination retreat for holistic healing, longevity, and environmental detoxification, integrating our advanced protocols in a pristine natural setting.
  • Phase 4: Scotland Longevity & Detox Clinic (2028)  
    Creating a flagship center in a historic Scottish castle, uniting all our expertise in precision mental health, longevity science, and holistic care.

Decentralized by Design

Spectruth is a DAO (Decentralized Autonomous Organization), governed by its community. Token holders shape research, clinic expansion, and IP strategy—ensuring transparency, inclusivity, and shared benefit.

Meet the Team: Passionate Experts Driving Innovation

 Our team combines expertise in mental health, technology, and decentralized governance.

James Holz retired as a successful litigation attorney specializing in securities law in 2019. Growing up on various military bases around the world, James witnessed firsthand the profound impact that post-traumatic stress disorder (PTSD) has on soldiers, their families, and communities. This personal experience fuels his passion for transforming innovative ideas into successful enterprises that make a difference. He graduated from Liberty University in 1999 and began his career in finance, excelling as a front-line specialist clerk on the New York Stock Exchange after being recognized as one of the top traders at WorldCo before becoming a securities attorney in 2007.  With a vision for the future, James aims to establish Spectruth as a leader in diagnostic testing and individualized therapeutic programs for individuals facing PTSD.  

 

Alexander Orlov, DO is a highly experienced physician and biotech advisor with over 25 years of expertise in regenerative medicine, private practice, and consulting.  Proven leader in advancing integrative health solutions and advising on biotech investments.  Committed to innovative approaches in patient care and business strategy.

 

Dr. Usmon Yuldashev is a doctor of infectious diseases, general practitioner and sports endocrinologist in medical rehabilitation center of Dijon, France and previously a highly respected resident infectious disease specialist, pharmacologist, and medical coordinator of the International Medical Platform in Kyiv, Ukraine. 

 

Iryna Bezborodko-Holz received her advanced education in Project Management in 2015 from Kharkiv National Agrarian University after earning her Bachelor's from Sumy National Agrarian University. Since 2016, Ms. Bezborodko has been a project manager for multiple startups.

 

Mike Lavore is our AI expert working with multiple Fortune 100 companies on deploying AI solutions across the healthcare space. Recent projects include computer-aided detection for radiology and augmented and virtual reality-based training solutions.  He graduated with honors from Florida Tech with a Master's degree in Business Administration to complement his Bachelor's in Computer and Information Science.

 

Mrs. Zhang is a Board Certified Behavior Analyst (BCBA) currently living in China. She has over ten years of experience working with children with developmental delays across Europe, the U.S.A., and China. She earned her Master of Science degree in Educational Studies from Katholieke Universiteit Leuven in Belgium. 

 

Illya Lozinsky is international lawyer to ensure all legal and ethical compliance. 

 

Solutions

Transformative Care, Personalized for You

  • Ibogaine Therapy for PTSD & Addiction
    Medically supervised, evidence-based treatment for trauma and substance use, available in Ukraine and Poland where legal frameworks allow.
  • Epigenetic Risk Prediction 
    Simple, non-invasive saliva tests identify biomarkers for PTSD risk, enabling proactive interventions before symptoms appear.
  • AI-Driven Personalized Protocols
    Machine learning analyzes your unique epigenetic and clinical data to recommend the most effective therapies—continuously refined by real-world results.

  • Holistic Longevity & Detox
    Our Patagonia and Scotland clinics offer advanced peptide therapies, EBOO blood filtration for microplastic removal, digital detox, and personalized health plans in restorative environments.
  • Open Science & Community Collaboration
    Participate in decentralized clinical trials, contribute data, and help drive the next generation of mental health and wellness innovation.

 

TECHNOLOGY

&

IMPACT

 

Where Science, Technology, and Community Meet
 

  • Epigenetic Biomarker Testing 
    Proprietary saliva-based tests detect DNA methylation patterns linked to PTSD and stress resilience, forming the foundation for early intervention.
  • AI & Machine Learning 
    Our agentic AI analyzes vast datasets—connecting trauma exposure, genetics, and treatment outcomes to optimize care for every individual.
  • Blockchain & IP-NFTs 
    All health records and research data are secured on-chain for privacy and interoperability. Our intellectual property, including diagnostic methods and AI protocols, is minted as IP-NFTs—creating value for the DAO and enabling open, transparent licensing.
  • Decentralized Clinical Trials 
    Spectruth’s clinics serve as real-world research hubs, collecting outcome data and refining protocols in partnership with patients, clinicians, and researchers worldwide.
     

The Spectruth DAO Token: Powering Decentralized Innovation

We are preparing to launch the Spectruth DAO token—a digital asset designed to empower our global community and fuel the next wave of mental health and longevity breakthroughs.
 

Token Utility Highlights:

  • Governance: Token holders will vote on key decisions, including research priorities, clinic expansion, and IP licensing—ensuring that our direction is truly community-driven.
  • Rewards & Revenue Sharing: Receive a share of profits from clinics, research commercialization, and IP-NFT licensing, directly linking token ownership to the project’s success.
  • Access & Benefits: Unlock early or discounted access to clinical services, participate in decentralized clinical trials, and gain exclusive insights into cutting-edge research.
  • Bounties & Collaboration: Earn tokens by contributing to research, data analysis, or community outreach—helping us accelerate discovery and impact.

  • Transparency: All funding, spending, and research outcomes are tracked on-chain, providing unmatched transparency and accountability for every stakeholder.
     

By integrating blockchain, AI, and decentralized science, the Spectruth DAO token transforms supporters into true partners—aligning incentives, accelerating innovation, and ensuring that the benefits of our breakthroughs are shared by all.

 

Contact Us

Join the Movement for Global Healing
 

Whether you’re a clinician, researcher, investor, or someone seeking transformative care, Spectruth welcomes you. Collaborate with us, participate in our trials, or help shape the future of mental health and longevity.
 

Email: press@spectruth.com

Founder: James Holz, Esq.

Discord: https://discord.gg/XrF3tVMxum

X (Twitter): Follow us @spectruthai
Telegram: t.me/SpectruthAI
 

Together, we can predict, prevent, and personalize healing—building a world where everyone has the opportunity to thrive.

 

Address:

08110, Ukraine, reg. Kyivska, district Kyievo-Sviatoshynskyi, town Mykhailivka-Rubezhivka, st. Chubynskoho, build 5, fl. 95

Name *
Email *
Country *

Spectruth DAO chose to operate as a decentralized autonomous organization (DAO) to fundamentally address the systemic conflicts of interest that often exist in traditional, for-profit pharmaceutical and mental health industries. This structure is central to Spectruth’s mission of delivering transparent, community-driven, and patient-focused solutions for PTSD and mental health care.
 

Why Spectruth Chose to Be a DAO


1. Community-Driven Governance and Transparency
Spectruth’s DAO model empowers token holders-including veterans, clinicians, researchers, and advocates-to directly participate in decision-making, research priorities, and resource allocation. This ensures that the direction of the project is shaped by those most affected by PTSD and those most invested in its resolution, rather than by a small group of corporate executives or profit-driven shareholders. All major decisions, from funding research to deploying new technologies, are made through transparent, on-chain voting, fostering accountability and trust.
 

2. Democratization of Innovation and Access
By leveraging a DAO, Spectruth removes traditional barriers to participation in mental health innovation. Anyone, anywhere can contribute data, expertise, or resources, and in return, share in the intellectual property and benefits generated by the project. This open, borderless approach contrasts with the closed, proprietary models typical of for-profit pharmaceutical companies, where access to research and benefits is often restricted.
 

3. Alignment of Incentives
Unlike for-profit pharmaceutical companies, which are often incentivized to maximize shareholder returns-sometimes at the expense of patients’ best interests-Spectruth’s DAO aligns incentives around community benefit and scientific progress. Token holders are rewarded based on the success and impact of the DAO’s initiatives, not just financial performance. This model encourages sustainable, long-term solutions over short-term profit.
 

4. Open Science and Shared Intellectual Property
Spectruth’s research outputs, including diagnostic algorithms and treatment protocols, are stored as NFTs on the blockchain, ensuring transparency, provenance, and shared ownership. This prevents monopolization of discoveries and allows the community to benefit collectively, rather than concentrating value in the hands of a few. Open-source principles and decentralized data sharing accelerate innovation and reduce the risk of data being withheld for competitive advantage.
 

How Spectruth Avoids Conflicts of Interest Seen in For-Profit Pharma


1. Decentralized Decision-Making
Decisions about research direction, funding, and partnerships are made collectively by DAO members, not by a centralized board or investors with profit motives. This reduces the risk of bias toward high-profit treatments and ensures that community needs drive priorities.


2. Transparent Funding and Resource Allocation
All transactions, funding decisions, and research grants are visible on-chain, allowing anyone to audit how resources are used and ensuring accountability. This transparency stands in stark contrast to opaque pharmaceutical funding and lobbying practices.
 

3. Patient and Community Empowerment
By giving patients, veterans, and advocates a direct voice in governance, Spectruth ensures that solutions are designed for real-world impact and accessibility, not just for marketability or profitability. This participatory model helps prevent the neglect of under-served populations and rare conditions that may not be lucrative for traditional pharma.
 

4. Open Collaboration and Partnerships
Spectruth’s ecosystem includes partnerships with government agencies, technology innovators, and research organizations. These collaborations are structured to maximize public benefit and knowledge sharing, rather than exclusive licensing or profit extraction.
 

In summary:


Spectruth DAO’s decentralized, transparent, and community-driven structure is designed to avoid the conflicts of interest that often plague for-profit pharmaceutical companies. By putting governance, innovation, and ownership in the hands of those most affected by PTSD, Spectruth ensures that its mission-precision, accessible, and effective mental health care-remains the top priority.